Imidazopyrazine Derivatives As Inhibitors of mTOR.
作者信息
Rosse Gerard
机构信息
Structure Guided Chemistry, Dart Neuroscience LLC , 7473 Lusk Boulevard, San Diego, California 92121, United States, and Adjunct Associate Professor, Department of Pharmacology and Physiology, Drexel University , College of Medicine, New College Building, 245 North 15th Street, Philadelphia, Pennsylvania 19102, United States.
出版信息
ACS Med Chem Lett. 2013 Apr 18;4(6):498-9. doi: 10.1021/ml400139e. eCollection 2013 Jun 13.
Abstract
摘要
相似文献
1
Imidazopyrazine Derivatives As Inhibitors of mTOR.咪唑并吡嗪衍生物作为mTOR的抑制剂
ACS Med Chem Lett. 2013 Apr 18;4(6):498-9. doi: 10.1021/ml400139e. eCollection 2013 Jun 13.
2
Molecular Design Strategy of Thermally Activated Delayed Fluorescent Emitters Using CN-Substituted Imidazopyrazine as a New Electron-Accepting Unit.采用 CN-取代的咪唑并吡嗪作为新型电子受单元的热激活延迟荧光发射器的分子设计策略。
Chem Asian J. 2020 Jan 2;15(1):122-128. doi: 10.1002/asia.201901311. Epub 2019 Nov 28.
3
[Synthesis of cypridina luciferin and related compounds. X. Chemiluminescence of imidazopyridine and imidazopyrazine derivatives].[海萤荧光素及相关化合物的合成。X. 咪唑并吡啶和咪唑并吡嗪衍生物的化学发光]
Yakugaku Zasshi. 1970 Dec;90(12):1475-9. doi: 10.1248/yakushi1947.90.12_1475.
4
Synthesis and anti-tumor activity of imidazopyrazines as TAK1 inhibitors.咪唑并吡嗪类作为 TAK1 抑制剂的合成与抗肿瘤活性。
Eur J Med Chem. 2019 Feb 1;163:660-670. doi: 10.1016/j.ejmech.2018.12.025. Epub 2018 Dec 13.
5
QSAR studies on imidazopyrazine derivatives as Aurora A kinase inhibitors.QSAR 研究咪唑并吡嗪衍生物作为 Aurora A 激酶抑制剂。
SAR QSAR Environ Res. 2012 Oct;23(7-8):705-30. doi: 10.1080/1062936X.2012.719541. Epub 2012 Sep 13.
6
Imidazo[1,2-a]pyrazine, Imidazo[1,5-a]quinoxaline and Pyrazolo[1,5-a]quinoxaline derivatives as IKK1 and IKK2 inhibitors.咪唑并[1,2-a]吡嗪、咪唑并[1,5-a]喹喔啉和吡唑并[1,5-a]喹喔啉衍生物作为 IKK1 和 IKK2 抑制剂。
Eur J Med Chem. 2017 Sep 29;138:909-919. doi: 10.1016/j.ejmech.2017.07.021. Epub 2017 Jul 19.
7
Probing the binding mechanism of Mnk inhibitors by docking and molecular dynamics simulations.通过对接和分子动力学模拟探究Mnk抑制剂的结合机制。
Biochemistry. 2015 Jan 13;54(1):32-46. doi: 10.1021/bi501261j. Epub 2014 Dec 5.
8
Sky-Blue Triplet Emitters with Cyclometalated Imidazopyrazine-Based NHC-Ligands and Aromatic Bulky Acetylacetonates.基于环金属化咪唑并吡嗪的 NHC-配体和芳香族大体积乙酰丙酮的天蓝色三重态发射器。
Chemistry. 2019 Nov 18;25(64):14495-14499. doi: 10.1002/chem.201903074. Epub 2019 Oct 9.
9
Chemistry around imidazopyrazine and ibuprofen: discovery of novel fatty acid amide hydrolase (FAAH) inhibitors.围绕咪唑并吡嗪和布洛芬的化学研究：新型脂肪酸酰胺水解酶（FAAH）抑制剂的发现。
Eur J Med Chem. 2010 Sep;45(9):3564-74. doi: 10.1016/j.ejmech.2010.04.040. Epub 2010 May 11.
10
Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors.靶向 mTOR 治疗疾病：mTOR 抑制剂的再评价综述。
Eur J Med Chem. 2020 Aug 1;199:112391. doi: 10.1016/j.ejmech.2020.112391. Epub 2020 May 4.
引用本文的文献
1
Microwave-assisted facile construction of quinoxalinone and benzimidazopyrazinone derivatives via two paths of post-Ugi cascade reaction.微波辅助通过两条后-Ugi 级联反应途径简便构建喹喔啉酮和苯并咪唑并吡嗪酮衍生物。
Mol Divers. 2019 Feb;23(1):137-145. doi: 10.1007/s11030-018-9855-y. Epub 2018 Aug 2.
本文引用的文献
1
mTOR is a key modulator of ageing and age-related disease.mTOR 是衰老和与年龄相关疾病的关键调节剂。
Nature. 2013 Jan 17;493(7432):338-45. doi: 10.1038/nature11861.
2
The Mammalian target of rapamycin inhibitors in breast cancer: current evidence and future directions.雷帕霉素靶蛋白抑制剂在乳腺癌中的应用：现有证据与未来方向。
Anticancer Res. 2013 Jan;33(1):21-8.
Zotero 插件